[ACRX] QoQ Quarter Result on 31-Mar-2019 [#Q1]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
09-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -8.89%
YoY- -17.96%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 475 608 941 265 613 377 818 -30.32%
PBT -14,423 -12,731 -12,409 -13,674 -12,558 -12,458 -10,539 23.19%
Tax 885 1,212 3 627 355 -2,601 2 5642.78%
NP -14,423 -12,731 -12,412 -13,674 -12,558 -12,458 -10,541 23.17%
Tax Rate - - - - - - - -
Total Cost 14,898 13,339 13,353 13,939 13,171 12,835 11,359 19.75%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin -3,036.42 -2,093.91 -1,319.02 -5,160.00 -2,048.61 -3,304.51 -1,288.63 76.79%
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
EPS -3.63 -3.20 -3.15 -3.47 -3.56 -4.15 -4.07 -7.32%
EPS Diluted -3.63 -3.20 -3.15 -3.47 -3.56 -4.15 -4.07 -7.32%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.